Peter D. Haytaian - 01 Mar 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & Pres Carelon & CarelonRx
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2023
Net transactions value: -$2,848,459
Form type: 4
Filing time: 03 Mar 2023, 15:17:21 UTC
Previous filing: 03 Nov 2022
Next filing: 03 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	$284,701	-607	-5.1%	$469.03	11,354	01 Mar 2023	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2,292	+20%	$0.000000	13,646	01 Mar 2023	Direct	F2
transaction	ELV	Common Stock	Award	$0	+9,716	+71%	$0.000000	23,362	01 Mar 2023	Direct	F3
transaction	ELV	Common Stock	Tax liability	$2,563,758	-5,469	-23%	$468.78	17,893	02 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+8,812		$0.000000	8,812	01 Mar 2023	Common Stock	8,812	$469.03	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
F3	Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4	The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.